
Pharma Pulse 3/19/24: AI’s Impact on CEO/Founder Sustainability, Practical Strategies to Repel Cyber Attacks & more
The latest news for pharma industry insiders.
In this Pharmaceutical Executive video interview, Kaveh Vahdat, Founder and President of RiseOpp, discusses the impact AI will have on thelong-term well-being of founders and CEOs.
Cyberattacks disproportionately affect healthcare organizations. In 2023, the average data breach cost to a healthcare company was $10.93 million, an 8% increase from the previous year.
The cyberattack that forced offline insurance clearinghouse Change Healthcare raises bigger questions about the digital security of the U.S. health care system.
SCHOTT Pharma plans to make Wilson, North Carolina home to its newest site. The investment is supported by $21 million in state and local incentive awards and will expand SCHOTT Group’s presence in the United States, a strategic market in its growth plan.
"When we look at the impact #biosimilars are having on #healthcare, it’s clear that savings are being realized and the landscape is rapidly changing; however, many questions remain unanswered. For example, how will the launch of more biosimilars impact patient choice? What’s being done to eliminate regulatory red tape and barriers to access for many of these medications? How much money could biosimilars save the US healthcare system as a whole?"
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.